An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial

MLA

McMahon, Jh, et al. An Adaptive Randomised Placebo Controlled Phase II Trial of Antivirals for COVID-19 Infection (VIRCO): A Structured Summary of a Study Protocol for a Randomised Controlled Trial. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1315721233&authtype=sso&custid=ns315887.

APA

McMahon, J., Lau, J., Roney, J., Rogers, B., Trubiano, J., Sasadeusz, J., Molton, J., Gardiner, B., Lee, S., Hoy, J., Cheng, A., & Peleg, A. (2020). An adaptive randomised placebo controlled phase II trial of antivirals for COVID-19 infection (VIRCO): A structured summary of a study protocol for a randomised controlled trial.

Chicago

McMahon, Jh, Jsy Lau, J Roney, Ba Rogers, J Trubiano, J Sasadeusz, Js Molton, et al. 2020. “An Adaptive Randomised Placebo Controlled Phase II Trial of Antivirals for COVID-19 Infection (VIRCO): A Structured Summary of a Study Protocol for a Randomised Controlled Trial.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1315721233&authtype=sso&custid=ns315887.